1. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, doi:10.3322/caac.21660 (2021).
2. Kauppila, J. H., Mattsson, F., Brusselaers, N. & Lagergren, J. Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study. BMJ Open8, e021495, doi:10.1136/bmjopen-2018-021495 (2018).
3. Jung, H. K. et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients. PLoS One15, e0231456, doi:10.1371/journal.pone.0231456 (2020).
4. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA: a cancer journal for clinicians70, 7-30, doi:10.3322/caac.21590 (2020).
5. Faiz, Z. et al. Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer. Annals of surgical oncology26, 986-995, doi:10.1245/s10434-019-07181-6 (2019).
6. Dolan, J. P. et al. Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer. Surg Endosc27, 4094-4103, doi:10.1007/s00464-013-3066-5 (2013).
7. Gottlieb-Vedi, E. et al. Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis. Annals of surgery270, 1005-1017, doi:10.1097/SLA.0000000000003252 (2019).
8. Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D. C. & Roudot-Thoraval, F. The burden of liver disease in Europe: a review of available epidemiological data. Journal of hepatology58, 593-608, doi:10.1016/j.jhep.2012.12.005 (2013).
9. Kalaitzakis, E., Gunnarsdottir, S. A., Josefsson, A. & Bjornsson, E. Increased risk for malignant neoplasms among patients with cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association9, 168-174, doi:10.1016/j.cgh.2010.10.014 (2011).
10. Randi, G. et al. History of cirrhosis and risk of digestive tract neoplasms. Annals of oncology : official journal of the European Society for Medical Oncology16, 1551-1555, doi:10.1093/annonc/mdi266 (2005).
11. Simmelink, A. et al. Perioperative Risk Assessment and Management of Cirrhotic Patients. J Hepatol Gastroint Dis1, doi:10.4172/2475-3181.1000101(2015).
12. Sabbagh, C., Fuks, D. & Regimbeau, J. M. Non-hepatic gastrointestinal surgery in patients with cirrhosis. Journal of visceral surgery151, 203-211, doi:10.1016/j.jviscsurg.2014.04.004 (2014).
13. Bhangui, P., Laurent, A., Amathieu, R. & Azoulay, D. Assessment of risk for non-hepatic surgery in cirrhotic patients. Journal of hepatology57, 874-884, doi:10.1016/j.jhep.2012.03.037 (2012).
14. Tachibana, M. et al. Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18 consecutive patients. Annals of surgical oncology7, 758-763, doi:10.1007/s10434-000-0758-6 (2000).
15. Sozzi, M., Siboni, S., Asti, E., Bonitta, G. & Bonavina, L. Short-Term Outcomes of Minimally Invasive Esophagectomy for Carcinoma In Patients with Liver Cirrhosis. Journal of laparoendoscopic & advanced surgical techniques. Part A27, 592-596, doi:10.1089/lap.2017.0115 (2017).
16. Wang, Z. Q. et al. Can oesophagectomy be performed for patients with oesophageal carcinoma and concomitant liver cirrhosis? A retrospective study based on a propensity-matched cohort. Interactive cardiovascular and thoracic surgery25, 442-447, doi:10.1093/icvts/ivx132 (2017).
17. Lu, M. S. et al. Is it safe to perform esophagectomy in esophageal cancer patients combined with liver cirrhosis? Interactive cardiovascular and thoracic surgery4, 423-425, doi:10.1510/icvts.2005.110387 (2005).
18. Valmasoni, M. et al. Esophageal Cancer Surgery for Patients with Concomitant Liver Cirrhosis: A Single-Center Matched-Cohort Study. Annals of surgical oncology24, 763-769, doi:10.1245/s10434-016-5610-8 (2017).
19. D'Amico, G., Garcia-Tsao, G. & Pagliaro, L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of hepatology44, 217-231, doi:10.1016/j.jhep.2005.10.013 (2006).
20. Asti, E., Sozzi, M., Bonitta, G., Bernardi, D. & Bonavina, L. Esophagectomy in patients with liver cirrhosis: a systematic review and Bayesian meta-analysis. Journal of visceral surgery155, 453-464, doi:10.1016/j.jviscsurg.2018.03.014 (2018).
21. Deng, H. Y. et al. Can we perform esophagectomy for esophageal cancer patients with concomitant liver cirrhosis? A comprehensive systematic review and meta-analysis. Dis Esophagus32, doi:10.1093/dote/doz003 (2019).
22. Schizas, D. et al. The impact of cirrhosis on esophageal cancer surgery: An up-to-date meta-analysis. Am J Surg220, 865-872, doi:10.1016/j.amjsurg.2020.02.035 (2020).
23. Jain, D., Mahmood, E., M, V. B. & Feyssa, E. Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery. Ann Gastroenterol31, 330-337, doi:10.20524/aog.2018.0249 (2018).
24. Kaser, S. A., Hofmann, I., Willi, N., Stickel, F. & Maurer, C. A. Liver Cirrhosis/Severe Fibrosis Is a Risk Factor for Anastomotic Leakage after Colorectal Surgery. Gastroenterol Res Pract2016, 1563037, doi:10.1155/2016/1563037 (2016).
25. Noor, M. T. & Manoria, P. Immune Dysfunction in Cirrhosis. Journal of clinical and translational hepatology5, 50-58, doi:10.14218/JCTH.2016.00056 (2017).
26. In, H. et al. Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Annals of surgery263, 286-291, doi:10.1097/SLA.0000000000001215 (2016).
27. Talsma, A. K., Lingsma, H. F., Steyerberg, E. W., Wijnhoven, B. P. & Van Lanschot, J. J. The 30-day versus in-hospital and 90-day mortality after esophagectomy as indicators for quality of care. Annals of surgery260, 267-273, doi:10.1097/SLA.0000000000000482 (2014).
28. Walters, D. M., McMurry, T. L., Isbell, J. M., Stukenborg, G. J. & Kozower, B. D. Understanding mortality as a quality indicator after esophagectomy. Ann Thorac Surg98, 506-511; discussion 511-502, doi:10.1016/j.athoracsur.2014.03.041 (2014).